InMode (INMD) Non-Current Deffered Revenue (2018 - 2025)
InMode (INMD) posted quarterly Non-Current Deffered Revenue of $3.0 million for Q4 2025, down 8.78% year-on-year from $3.3 million in Q4 2024, and down 8.78% on a QoQ basis from $3.3 million in Q4 2024.
InMode (INMD) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends
InMode (INMD) has reported Non-Current Deffered Revenue for 8 consecutive years, with $3.0 million the latest figure, recorded in Q4 2025.
- Quarterly Non-Current Deffered Revenue fell 8.78% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (down 8.78% YoY) and the FY2025 annual result came in at $3.0 million, down 8.78% from the prior year.
- Non-Current Deffered Revenue retreated to $3.0 million in Q4 2025 per INMD's latest filing, from $3.3 million in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for INMD reached as high as $9.3 million in Q1 2024 and fell as low as $2.8 million in Q4 2021.
- A 5-year average of $4.3 million and a median of $3.8 million in 2023 frame the typical range for Non-Current Deffered Revenue.
- The largest YoY upside for Non-Current Deffered Revenue was 135.91% in 2024 against a maximum downside of 11.42% in 2024.
- Year by year, Non-Current Deffered Revenue stood at $2.8 million in 2021, then soared by 43.91% to $4.0 million in 2022, then declined by 4.87% to $3.8 million in 2023, then retreated by 11.42% to $3.3 million in 2024, then slipped by 8.78% to $3.0 million in 2025.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $3.0 million, $3.3 million, and $9.3 million for Q4 2025, Q4 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 512.79 Mn |
| 10 | InMode | 975,741.41 | -479.15 Mn | 61.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Mar 31, 2024 | 9.26 Mn |
| Dec 31, 2023 | 3.77 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Dec 31, 2022 | 3.96 Mn |
| Dec 31, 2021 | 2.75 Mn |
| Dec 31, 2020 | 1.99 Mn |
| Dec 31, 2019 | 3.81 Mn |
| Dec 31, 2018 | 3.98 Mn |